PAVmed Inc.
PAVM | NASDAQ
$3.97
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$4.16
+$0.19 (+4.79%)
Pre-market:
Sep 22, 2026, 7:57 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 71K | 3M | 2.45M | 377K | 500K | n/a |
Cost of Revenue | 323K | 6.04M | 6.42M | 3.61M | 585K | n/a |
Gross Profit | -252K | -3.04M | -3.97M | -3.24M | -85K | n/a |
Operating Income | -21.81M | -44.49M | -68.8M | -91.09M | -54.39M | -23.35M |
Interest Income | 29K | 254K | 505K | 169K | n/a | 53K |
Pretax Income | -2.47M | 28.43M | -79.26M | -103.24M | -56.13M | -35.89M |
Net Income | 401K | 39.79M | -64.18M | -88.98M | -50.35M | -34.28M |
Selling & General & Admin | 17.17B | 36.15M | 48.53M | 60.73M | 34.32M | 12.39M |
Research & Development | 4.49B | 5.93M | 14.28M | 25.34M | 19.85M | 10.96M |
Other Expenses | -21.64B | -639K | 2.02M | 1.78M | 146K | n/a |
Operating Expenses | 21.55M | 41.44M | 64.83M | 87.85M | 54.31M | 23.35M |
Interest Expense | 21K | 45K | 589K | 1.28M | n/a | 53K |
Selling & Marketing Expenses | 917M | 11.63M | 17.58M | 19.32M | 8.9M | 2.79M |
Cost & Expenses | 21.88M | 47.48M | 71.25M | 91.46M | 54.89M | 23.35M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 670.47K | 322.41K | 241.05K | 197.95K | 172.26K | 105.41K |
Shares Outstanding (Diluted) | 670.47K | 2.18M | 241.05K | 197.95K | 172.26K | 105.41K |
EPS (Basic) | -5.63 | 99.15 | -274.92 | -450.95 | -293.92 | -327.91 |
EPS (Diluted) | -5.63 | 14.88 | -274.92 | -450.95 | -293.92 | -327.91 |
EBITDA | -2.34M | 29.67M | -75.74M | -99.5M | -55.9M | -23.33M |
EBIT | -2.45M | 28.47M | -78.67M | -101.96M | -56.13M | -23.35M |
Depreciation & Amortization | 105K | 1.2M | 2.93M | 2.46M | 226K | 23K |
Add to Watchlist
Select watchlists to add or remove PAVM